| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3-phosphoinositide-dependent protein kinase activity | 7.73e-06 | 2 | 56 | 2 | GO:0004676 | |
| Domain | Helicase_C | 3.67e-03 | 107 | 54 | 3 | PF00271 | |
| Domain | HELICc | 3.67e-03 | 107 | 54 | 3 | SM00490 | |
| Domain | Helicase_C | 3.76e-03 | 108 | 54 | 3 | IPR001650 | |
| Domain | SNF2_N | 3.85e-03 | 32 | 54 | 2 | IPR000330 | |
| Domain | SNF2_N | 3.85e-03 | 32 | 54 | 2 | PF00176 | |
| Domain | HELICASE_CTER | 3.86e-03 | 109 | 54 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.86e-03 | 109 | 54 | 3 | PS51192 | |
| Domain | DEXDc | 3.86e-03 | 109 | 54 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.96e-03 | 110 | 54 | 3 | IPR014001 | |
| Domain | PX | 7.18e-03 | 44 | 54 | 2 | SM00312 | |
| Domain | Ldl_recept_a | 7.50e-03 | 45 | 54 | 2 | PF00057 | |
| Domain | - | 7.83e-03 | 46 | 54 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 8.50e-03 | 48 | 54 | 2 | PS01209 | |
| Domain | PX | 8.85e-03 | 49 | 54 | 2 | PF00787 | |
| Domain | LDLRA_2 | 8.85e-03 | 49 | 54 | 2 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 8.85e-03 | 49 | 54 | 2 | IPR002172 | |
| Domain | LDLa | 8.85e-03 | 49 | 54 | 2 | SM00192 | |
| Domain | PX | 9.20e-03 | 50 | 54 | 2 | PS50195 | |
| Domain | - | 9.56e-03 | 51 | 54 | 2 | 3.30.1520.10 | |
| Domain | Phox | 9.92e-03 | 52 | 54 | 2 | IPR001683 | |
| Pubmed | The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development. | 2.64e-06 | 2 | 57 | 2 | 15077109 | |
| Pubmed | Epinephrine-induced hyperpolarization of pancreatic islet cells is sensitive to PI3K-PDK1 signaling. | 2.64e-06 | 2 | 57 | 2 | 19716369 | |
| Pubmed | PDK1 Is Required for Maintenance of CD4+ Foxp3+ Regulatory T Cell Function. | 2.64e-06 | 2 | 57 | 2 | 33789982 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 36726025 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 10075713 | ||
| Pubmed | Reduced intestinal and renal amino acid transport in PDK1 hypomorphic mice. | 2.64e-06 | 2 | 57 | 2 | 17077298 | |
| Pubmed | 3'Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium. | 2.64e-06 | 2 | 57 | 2 | 17077284 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 23444402 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 16751192 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 25601552 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 27286918 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 25546417 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 20944007 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 20051528 | ||
| Pubmed | Phosphoinositide-dependent kinase PDK1 in the regulation of Ca2+ entry into mast cells. | 2.64e-06 | 2 | 57 | 2 | 21063107 | |
| Pubmed | Activation of PDK-1 maintains mouse embryonic stem cell self-renewal in a PKB-dependent manner. | 2.64e-06 | 2 | 57 | 2 | 23455320 | |
| Pubmed | In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation. | 2.64e-06 | 2 | 57 | 2 | 12912918 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 33377210 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 11702203 | ||
| Pubmed | Essential role of PDK1 in regulating endothelial cell migration. | 2.64e-06 | 2 | 57 | 2 | 17371830 | |
| Pubmed | In vivo role of the phosphate groove of PDK1 defined by knockin mutation. | 2.64e-06 | 2 | 57 | 2 | 16219676 | |
| Pubmed | Reduced Ca2+ entry and suicidal death of erythrocytes in PDK1 hypomorphic mice. | 2.64e-06 | 2 | 57 | 2 | 17899170 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 16923125 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19088454 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19088455 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 15531926 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 22108800 | ||
| Pubmed | The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation. | 2.64e-06 | 2 | 57 | 2 | 15116068 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 25645675 | ||
| Pubmed | Nonobese diabetic CD4 lymphocytosis maps outside the MHC locus on chromosome 17. | 2.64e-06 | 2 | 57 | 2 | 15309345 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 12923190 | ||
| Pubmed | Essential role of PDK1 in regulating cell size and development in mice. | 2.64e-06 | 2 | 57 | 2 | 12110585 | |
| Pubmed | The effect of PDK1 in maintaining immune cell development and function. | 2.64e-06 | 2 | 57 | 2 | 38795634 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 16563390 | ||
| Pubmed | PDK1 Activity Regulates Proliferation, Invasion and Growth of Hemangiomas. | 2.64e-06 | 2 | 57 | 2 | 26202351 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 33300048 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 32457586 | ||
| Pubmed | T regulatory cells maintain intestinal homeostasis by suppressing γδ T cells. | 2.64e-06 | 2 | 57 | 2 | 21074460 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 31055616 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 12855688 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 22119465 | ||
| Pubmed | Role of PDK1 in insulin-signaling pathway for glucose metabolism in 3T3-L1 adipocytes. | 2.64e-06 | 2 | 57 | 2 | 12006370 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 14623982 | ||
| Pubmed | The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma. | 2.64e-06 | 2 | 57 | 2 | 27802184 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 27339458 | ||
| Pubmed | The Rb-family protein p107 inhibits translation by a PDK1-dependent mechanism. | 2.64e-06 | 2 | 57 | 2 | 12420226 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17991746 | ||
| Pubmed | Pancreatic beta cell mass preserved in heterozygous PDK1 knockout mice. | 2.64e-06 | 2 | 57 | 2 | 19246967 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 20978239 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 11877406 | ||
| Pubmed | Impaired intestinal and renal glucose transport in PDK-1 hypomorphic mice. | 2.64e-06 | 2 | 57 | 2 | 16741145 | |
| Pubmed | PI3 kinase and PDK1 in the regulation of the electrogenic intestinal dipeptide transport. | 2.64e-06 | 2 | 57 | 2 | 20511717 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 25912234 | ||
| Pubmed | Evaluation of approaches to generation of tissue-specific knock-in mice. | 2.64e-06 | 2 | 57 | 2 | 16887794 | |
| Pubmed | The kinase PDK1 is essential for B-cell receptor mediated survival signaling. | 2.64e-06 | 2 | 57 | 2 | 23393571 | |
| Pubmed | Deletion of PDK1 causes cardiac sodium current reduction in mice. | 2.64e-06 | 2 | 57 | 2 | 25781322 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19423553 | ||
| Pubmed | Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia. | 2.64e-06 | 2 | 57 | 2 | 12970179 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 12054753 | ||
| Pubmed | Analysis of 3-phosphoinositide-dependent kinase-1 signaling and function in ES cells. | 2.64e-06 | 2 | 57 | 2 | 18514190 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17027005 | ||
| Pubmed | Phosphoinositide 3-kinase signalling regulates early development and developmental haemopoiesis. | 2.64e-06 | 2 | 57 | 2 | 17456549 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17617409 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 26476238 | ||
| Pubmed | Deficiency of PDK1 in osteoclasts delays fracture healing and repair. | 2.64e-06 | 2 | 57 | 2 | 32626968 | |
| Pubmed | PDK1 plays a vital role on hematopoietic stem cell function. | 7.91e-06 | 3 | 57 | 2 | 28694518 | |
| Pubmed | The kinase PDK1 is critical for promoting T follicular helper cell differentiation. | 7.91e-06 | 3 | 57 | 2 | 33595435 | |
| Pubmed | Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. | 7.91e-06 | 3 | 57 | 2 | 16642023 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 32048762 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 18184863 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 27103434 | ||
| Pubmed | Stage-specific requirement of kinase PDK1 for NK cells development and activation. | 7.91e-06 | 3 | 57 | 2 | 30622306 | |
| Pubmed | PDK1 plays a critical role in regulating cardiac function in mice and human. | 7.91e-06 | 3 | 57 | 2 | 21034549 | |
| Pubmed | Reciprocal negative regulation of PDK1 and ASK1 signaling by direct interaction and phosphorylation. | 7.91e-06 | 3 | 57 | 2 | 19920149 | |
| Pubmed | Regulation of novel protein kinase C epsilon by phosphorylation. | 7.91e-06 | 3 | 57 | 2 | 11964154 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 36988860 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 25259869 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 29358916 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 12372837 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 23131847 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 18591395 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 17267763 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 21297860 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 19065678 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 31894307 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 20609497 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 18347057 | ||
| Pubmed | PDK1 promotes the inflammatory progress of fibroblast-like synoviocytes by phosphorylating RSK2. | 7.91e-06 | 3 | 57 | 2 | 28314444 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 31208986 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 16150867 | ||
| Pubmed | FasL-PDPK1 Pathway Promotes the Cytotoxicity of CD8+ T Cells During Ischemic Stroke. | 7.91e-06 | 3 | 57 | 2 | 32036560 | |
| Pubmed | PDK1 promotes tumor growth and metastasis in a spontaneous breast cancer model. | 7.91e-06 | 3 | 57 | 2 | 26455327 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 34918060 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 19703999 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 31578203 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 18718528 | ||
| Pubmed | Akt signaling is critical for memory CD8+ T-cell development and tumor immune surveillance. | 7.91e-06 | 3 | 57 | 2 | 28137869 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 16314505 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 16785309 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 33579325 | ||
| Cytoband | 3q26.31 | 1.80e-04 | 16 | 57 | 2 | 3q26.31 | |
| Cytoband | 3p21.1 | 1.26e-03 | 42 | 57 | 2 | 3p21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 1.96e-03 | 426 | 57 | 4 | chr16p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q35 | 3.16e-03 | 235 | 57 | 3 | chr5q35 | |
| Cytoband | 1p36.11 | 3.27e-03 | 68 | 57 | 2 | 1p36.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q42 | 3.35e-03 | 240 | 57 | 3 | chr1q42 | |
| Cytoband | 16p13.3 | 3.51e-03 | 244 | 57 | 3 | 16p13.3 | |
| Cytoband | 2q37.3 | 4.17e-03 | 77 | 57 | 2 | 2q37.3 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.83e-06 | 191 | 55 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.57e-06 | 198 | 55 | 5 | dbd7869483c5a67944cb94ced0ee2c7b999adc2e | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.57e-06 | 198 | 55 | 5 | 8f64bb5cd8c3e2d5ef651821b0d59f67d1ca1a12 | |
| ToppCell | medial-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.57e-06 | 198 | 55 | 5 | 432a26ace5b486695c9a933c0d44b73305b01ded | |
| ToppCell | distal-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.68e-06 | 199 | 55 | 5 | 5e209df67cfe8ac7437cc363f1c5c3166bfae1af | |
| ToppCell | Severe-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.79e-06 | 200 | 55 | 5 | 80639e0d2ddaae36ac7634a4f03e8809af7316e3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 159 | 55 | 4 | 9f6607e395bcca9cb1c83199bdbbaaa62a93938d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 159 | 55 | 4 | c8b42ebc25ebcc450832096fbffaa5c5f5fe88e7 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.51e-05 | 168 | 55 | 4 | cc0dd43d5cda01e643d8e8d74ec7617d61890760 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.77e-05 | 170 | 55 | 4 | 6ec0cf055ae55e9fac147f7989c47f83ab07270c | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.91e-05 | 171 | 55 | 4 | 539ea88acc6f948efdeae8b69e5c5ffaee29f1d9 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-05 | 172 | 55 | 4 | 0fc692be845d4225ff8b63bf9195724fc8510c2c | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.04e-05 | 172 | 55 | 4 | c96bd3407911df3e3e6d7a3dba786b11814b9598 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.60e-05 | 176 | 55 | 4 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.60e-05 | 176 | 55 | 4 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.75e-05 | 177 | 55 | 4 | f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1 | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.90e-05 | 178 | 55 | 4 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 7.05e-05 | 179 | 55 | 4 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 180 | 55 | 4 | 87347af8f28cf7c486c19f3f98c0afb022c323b5 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 182 | 55 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 182 | 55 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.85e-05 | 184 | 55 | 4 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 8.01e-05 | 185 | 55 | 4 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.01e-05 | 185 | 55 | 4 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.01e-05 | 185 | 55 | 4 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.18e-05 | 186 | 55 | 4 | 74c238759c5d3fd39127ec0060d0c2cb16b326d4 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.18e-05 | 186 | 55 | 4 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-05 | 186 | 55 | 4 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 8.18e-05 | 186 | 55 | 4 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.18e-05 | 186 | 55 | 4 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.35e-05 | 187 | 55 | 4 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 189 | 55 | 4 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | IPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 8.70e-05 | 189 | 55 | 4 | 5c22d2d935f7bb270260b8bc6be67b565ec401bf | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 189 | 55 | 4 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | IPF-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 8.88e-05 | 190 | 55 | 4 | f9c2a13c7f6460e3b348581be855b7281c8f70b5 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.06e-05 | 191 | 55 | 4 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.43e-05 | 193 | 55 | 4 | cb0fb21510124883e716780bea46575620c366b8 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.43e-05 | 193 | 55 | 4 | 0c207879f994c227dcd1322faa69ec9e3749cdaa | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.43e-05 | 193 | 55 | 4 | 0fbbfcc803edc3cd96b35467ad5cc573af07fd67 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-05 | 194 | 55 | 4 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.62e-05 | 194 | 55 | 4 | ac203d388a3a3884e316dec0dcbd408e43c6ef6c | |
| ToppCell | medial-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.62e-05 | 194 | 55 | 4 | 202e5070728191c46161fa7d931f00be1c7559d4 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.62e-05 | 194 | 55 | 4 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.62e-05 | 194 | 55 | 4 | 002cd317732fc6b0d9a72fb46199f71db5a638a7 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.82e-05 | 195 | 55 | 4 | 6f417bb464b8ae6a50bbab5db5a6d5760c02122f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.82e-05 | 195 | 55 | 4 | 9cfbdb528088ad0ab100c7431c7d8f140a846de8 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.82e-05 | 195 | 55 | 4 | 935461e849ca4d17627341b3ae5124d497793a91 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 9.82e-05 | 195 | 55 | 4 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | distal-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.82e-05 | 195 | 55 | 4 | 34bed73e4dae34b0f1076b7ff9dc7ea2096c1796 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 9.82e-05 | 195 | 55 | 4 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.82e-05 | 195 | 55 | 4 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.82e-05 | 195 | 55 | 4 | 66f3b3e15eaa21bc7cf2f204cac81de1a160a748 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.82e-05 | 195 | 55 | 4 | bbf5f79be4fcea754328f1af7ee5625075248100 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.82e-05 | 195 | 55 | 4 | 7dd0cb8f3753fe761fac200cbd161708b6528c51 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil-promyelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.00e-04 | 196 | 55 | 4 | 8ff0135e108764a3527acc00a994ced342e1cad1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 196 | 55 | 4 | 3dc6394c5de1f875a19ad0e8799827fad29f8f02 | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 1.00e-04 | 196 | 55 | 4 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.00e-04 | 196 | 55 | 4 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-promyelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.02e-04 | 197 | 55 | 4 | 6fe4a9f67291a7e4260984e901d069ff1746d0be | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.02e-04 | 197 | 55 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.02e-04 | 197 | 55 | 4 | e817c1a8549e403e723b1b6c73cdb04f1179909d | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.02e-04 | 197 | 55 | 4 | 6fe013f98c64b3c5a4e61002254717fb411f8e59 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 1.04e-04 | 198 | 55 | 4 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| ToppCell | Severe-B_intermediate-10|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.04e-04 | 198 | 55 | 4 | dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 198 | 55 | 4 | 273a9e24438c31c1d3fc3ad71efbfafb54747476 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD8+_T_naive|URO / Disease, condition lineage and cell class | 1.04e-04 | 198 | 55 | 4 | c07426d4119b53e58eb5f448ae364f47cac1fc5c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 198 | 55 | 4 | 9375a9fd31393709e1e3078f4b130e9e71a37c13 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-04 | 198 | 55 | 4 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 1.06e-04 | 199 | 55 | 4 | 3feee9f53860b4b2e93ff2360beb2b2b74f51d24 | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 199 | 55 | 4 | f393f8d2b9711e71beb4f1c5e7cac5acb047fd0e | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 199 | 55 | 4 | fa362f3e456a4853652e52d54e76473809eea76d | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 55 | 4 | 179afc4bee7a2fd85a3b5dadf32544a63807c164 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 55 | 4 | 83d9aa5b46ae7a71a258b2e44b3251f95bc9a1b7 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-04 | 200 | 55 | 4 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 55 | 4 | d39bf03817b76c9dfcbcd868341b51bb8601ea9b | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 55 | 4 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.08e-04 | 200 | 55 | 4 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 55 | 4 | f78968d4b4d907094b2c44dcf5ac557ae94e4484 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 55 | 4 | 0855ebb10b925664aa5cf813d97e97683c46180d | |
| Disease | dentate gyrus volume measurement | 5.05e-05 | 39 | 54 | 3 | EFO_0010083 | |
| Disease | hippocampal CA4 volume | 5.88e-05 | 41 | 54 | 3 | EFO_0009396 | |
| Disease | sitting height ratio | 1.13e-04 | 51 | 54 | 3 | EFO_0007118 | |
| Disease | age-related hearing impairment | 3.15e-04 | 324 | 54 | 5 | EFO_0005782 | |
| Disease | asparaginase hypersensitivity | 3.85e-04 | 77 | 54 | 3 | EFO_0004881 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 5.51e-04 | 19 | 54 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 5.51e-04 | 19 | 54 | 2 | C2936783 | |
| Disease | balding measurement | 5.78e-04 | 792 | 54 | 7 | EFO_0007825 | |
| Disease | skin hydration measurement | 6.75e-04 | 21 | 54 | 2 | EFO_0009586 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 1.04e-03 | 26 | 54 | 2 | C0009405 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 1.12e-03 | 27 | 54 | 2 | C1112155 | |
| Disease | erythrocyte measurement | 1.26e-03 | 257 | 54 | 4 | EFO_0005047 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 1.29e-03 | 29 | 54 | 2 | C1333990 | |
| Disease | presubiculum volume | 1.48e-03 | 31 | 54 | 2 | EFO_0009400 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KRIVVYHPKIEAVQE | 181 | Q6NSW5 | |
| KVVNAYHLRVRRKNP | 431 | P54646 | |
| RFHIQRNVIVIPKSV | 251 | O60218 | |
| QKKVPHRDFYNIRKV | 401 | Q01433 | |
| DQFVHPQKRILIRKV | 61 | Q86XH1 | |
| VIVQIKQPRKKYVQR | 361 | Q8TDF5 | |
| KHIKVNRPIGRVQIF | 1871 | Q96L73 | |
| YKQNDVVRILPCKHV | 271 | Q86XS8 | |
| HNAVVKAIPVRRVEK | 686 | Q8NFP4 | |
| RNKHIRTPVKVNFYV | 646 | Q13469 | |
| IYKRKGTLQIHPVVI | 316 | Q9NRZ9 | |
| LKQVRNYIKEHSPRQ | 241 | Q6PEV8 | |
| QIKPYIRHKDVNVRV | 566 | Q6AI08 | |
| LEKRHIIKENKVPYV | 86 | Q6A1A2 | |
| KPRVKEHYRANKVNL | 631 | Q8N2Q7 | |
| LKVQYHPRDQNKVLV | 111 | Q15291 | |
| RVTTPNVVKHIRDYK | 171 | P15863 | |
| HPRKIEIERRKQQYL | 186 | Q9P2D7 | |
| QVEILNRYPHFKTKI | 106 | P07099 | |
| VIEKIRYVPEQKEHR | 401 | Q9H2U1 | |
| AYPKRRKTVNQDVHI | 881 | Q99698 | |
| KVRLQVQSVEKPQYR | 26 | Q8N8R3 | |
| YIIIFHPELNVQKRK | 846 | Q14831 | |
| KRIVVYHPKIEAVQE | 181 | Q8TCE6 | |
| VEKVNIKPQVDRYRL | 316 | P23526 | |
| EPHVIRVQKKIVANR | 581 | Q8TDX9 | |
| YNPRLTVIVVKKRVN | 731 | Q96J94 | |
| RQRVVHDFPKYSVKV | 226 | Q7RTN6 | |
| AKIIRHPKYNRIILN | 91 | Q8NHM4 | |
| QLRQYHRLTKQIKPD | 131 | O95926 | |
| VRKVNESIKYNHPLR | 251 | Q68DH5 | |
| RHIIKENKVPYVTRE | 116 | O15530 | |
| IAVVHPLRYNKIKRI | 131 | P32249 | |
| RPVIVAYKKNLVEQH | 406 | P04843 | |
| PRENQPIHREKVKRY | 461 | Q9P2F8 | |
| RRIKLYQKPEGNHII | 196 | Q149N8 | |
| LYPVQQTIHELQRKI | 1121 | Q149N8 | |
| RKRLTPLQYHVTQEK | 51 | Q8IXL7 | |
| AKYVKTHQVIARRQE | 26 | Q8TAY7 | |
| PIHVRKYKGQVVAVD | 16 | Q9UQ84 | |
| QRQEQRPVEKKPLYH | 506 | Q9UKE5 | |
| RHFYQRKKVPVSVNL | 171 | O76021 | |
| VVDVEKRRNPSKHYV | 11 | Q5TCZ1 | |
| KRRNPSKHYVYIINV | 16 | Q5TCZ1 | |
| KVLDVQKRRVPNKHY | 11 | A1X283 | |
| QKRRVPNKHYVYIIR | 16 | A1X283 | |
| QKVRKEEIPRQLQYI | 181 | Q15035 | |
| VRAQVVQIVKHPLYN | 271 | Q7Z410 | |
| QVEPEIKRKVQQKRH | 196 | Q9GZR1 | |
| KYPREVKIHNRNSTI | 1261 | P08922 | |
| VHNITRKVTNRKYPK | 31 | Q9Y2Y1 | |
| LQIVHTKEQPYKRYV | 461 | Q9UJU3 | |
| YAQQREKPRVQEKQH | 316 | Q15942 | |
| RHPEIKVTAKYIRQA | 1136 | Q96JM2 | |
| ARVYKQRKIAVVQPE | 456 | Q9UHJ3 | |
| ITQVFHVPLEERKYK | 76 | Q00341 | |
| AKIIRHPQYDRKTLN | 91 | P07477 | |
| VKINQHKRCPDYIIQ | 781 | P08575 | |
| LIQPRRKKAYQLEHT | 76 | Q86UU9 | |
| KQVEHKPSQSYLRVR | 1436 | Q9BVV6 |